BioSpace News Archive

Glaucoma is a disease that damages the optic nerve and its progression could result in vision loss and blindness.

The global immunoglobulins market is expected to reach a market value of about US$ 20,757 Mn by the end of 2026, expanding at a high single digit CAGR during the forecast period.

The global spine surgery robots market was valued at more than US$ 75 Mn in 2017 and is anticipated to reach US$ 320 Mn by 2026.

Adaptive Biotechnologies Corporation announced it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada.

Baudax Bio, Inc., a pharmaceutical company focused on innovative products for acute care settings, announced that it will report first quarter 2022 financial results on Thursday, May 5, 2022.

Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it will report its first quarter financial results along with recent company highlights after the close of the U.S. financial markets on Thursday, May 5, 2022.

SeaSpine Holdings Corporation announced the full commercial launch of OsteoTorrent and OsteoTorrent C, both of which are new Accell DBM Putties packaged and sterilized in a dry state and designed to further improve osteoinductive potential and shelf-life, while allowing surgeons to reconstitute with saline, blood or bone marrow aspirate.

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), today announced 510k clearance for use of the KORU Medical FreedomEdge® infusion system to deliver pegcetacoplan 20 mL solution, branded as EMPAVELI® or Aspaveli® and commercialized by Apellis in the United States and by Sobi outside the United States.

The global hip replacement implants market size was valued at US$ 5.2 billion in 2020 and is projected to hit US$ 7 billion by 2030.

The global Fusion Biopsy market size is expected to surpass around US$ 3.12 billion by 2030 and is anticipated to grow at a CAGR of 13.6% during forecast period 2021 to 2030.